SEC Form 4 Summary ORKA

Oruka Therapeutics' Joana Goncalves Sells 7,000 Shares

Oruka Therapeutics (ORKA) Chief Medical Officer Joana Goncalves sold 7,000 shares for $706,699.72 in six transactions.

Transaction Value:
$706,699.72
Shares transacted:
7,000
Average price:
$100.96
Insider:

The Form 4 filing, which reports insider stock activity to the SEC, was submitted on November 16, 2026. All six sales took place that day.

Oruka Therapeutics is a biotechnology company in the healthcare sector. Joana Goncalves serves as its chief medical officer.

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellsell
Transaction Count6
Shares Transacted7,000
Price$100.96
Total Transaction Value$706,699.72
Insider
Ticker SymbolORKA
CompanyOruka Therapeutics, Inc.
Insider NameGoncalves Joana
Insider TitleChief Medical Officer
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction31,771
Position Size Change18.05%
Filing
Filing Date2026-11-16
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of ORKA shares, reported with transaction code S. The filing covers six sale transactions by one insider, Joana Goncalves.

What was the average price of the transaction?

The average sale price was $100.96 per share across the six transactions.

How did this transaction affect the insider's holdings?

The sale involved 7,000 shares, leaving 31,771 shares reported as owned afterward. The shares sold made up 18.05% of the shares reported as owned before the sale.

What's the total transaction value?

The total value was $706,699.72 for all six sales.

Are there any special circumstances around this transaction?

Yes. The available information includes a Rule 10b5-1 trading-plan reference for this filing. These plans set trading instructions in advance. The reference may apply to the filing as a whole. No footnote text was provided to confirm which of the six sales it covers. The plan's start date and trading schedule are unknown. The reference does not show why the shares were sold.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.